» Articles » PMID: 39887540

SELective Defunctioning Stoma Approach in Low Anterior Resection for Rectal Cancer (SELSA): Protocol for a Prospective Study with a Nested Randomized Clinical Trial Investigating Stoma-free Survival Without Major LARS Following Total Mesorectal...

Abstract

Aim: Accumulated data suggest that routine use of defunctioning stoma in low anterior resection for rectal cancer may cause kidney injury, bowel dysfunction and a higher risk of permanent stomas. We aim to study whether avoidance of a diverting stoma in selected patients is safe and reduces adverse consequences.

Methods: SELSA is a multicentre international prospective observational study nesting an open-label randomized clinical trial. All patients with primary rectal cancer planned for low anterior resection are eligible. Patients operated with curative intent, aged <80 years, with an American Society of Anaesthesiologists' fitness grade I or II, and a low predicted risk of anastomotic leakage are eligible to 1:1 randomization between no defunctioning stoma (experimental arm) or a defunctioning stoma (control arm). The primary outcome is the composite measure of 2-year stoma-free survival without major low anterior resection syndrome (LARS). Secondary outcomes include anastomotic leakage, postoperative mortality, reinterventions, stoma-related complications, quality of life measures, LARS score, and permanent stoma rate. To be able to state superiority of any study arm regarding the main outcome, with 90% statistical power and assuming 25% attrition, we aim to enrol 212 patients. Patient inclusion will commence in the autumn of 2024.

Conclusion: The SELSA study is investigating a tailored approach to defunctioning stoma use in low anterior resection for rectal cancer in relation to the risk of anastomotic leakage. Our hypothesis is that long-term effects will favour the selective approach, enabling some patients to avoid a defunctioning stoma.

Trial Registration: Swedish Ethical Review Authority approval (2023-04347-01, 2024-02418-02 and 2024-03622-02), Regional Ethics Committee Denmark (H-24014463), and ClinicalTrials.gov (NCT06214988).

Citing Articles

SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma-free survival without major LARS following total mesorectal....

Rutegard M, Lindskold M, Jorgren F, Landerholm K, Matthiessen P, Forsmo H Colorectal Dis. 2025; 27(2):e70009.

PMID: 39887540 PMC: 11780343. DOI: 10.1111/codi.70009.

References
1.
Stark P, Myles P, Burke J . Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013; 118(6):1332-40. DOI: 10.1097/ALN.0b013e318289b84b. View

2.
Varghese C, Wells C, OGrady G, Christensen P, Bissett I, Keane C . The Longitudinal Course of Low-anterior Resection Syndrome: An individual Patient Meta-analysis. Ann Surg. 2022; 276(1):46-54. DOI: 10.1097/SLA.0000000000005423. View

3.
Gadan S, Lindgren R, Floodeen H, Matthiessen P . Reversal of defunctioning stoma following rectal cancer surgery: are we getting better? A population-based single centre experience. ANZ J Surg. 2019; 89(4):403-407. DOI: 10.1111/ans.14990. View

4.
Gustafsson U, Scott M, Hubner M, Nygren J, Demartines N, Francis N . Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: 2018. World J Surg. 2018; 43(3):659-695. DOI: 10.1007/s00268-018-4844-y. View

5.
Matthiessen P, Hallbook O, Rutegard J, Simert G, Sjodahl R . Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2007; 246(2):207-14. PMC: 1933561. DOI: 10.1097/SLA.0b013e3180603024. View